Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
∫˙ÂÈ˙Ù¯˙≠ÔÈ·†˙·‚˙ ¨‰ÂÊ˙†ÈÙÒÂ˙Â†Ì˘¯Ó†‡Ïφ˙¯ÎÓ‰†˙ÂÙ¯˙†ÏÏÂΆ¨˙ÙÒ†‰Ù¯˙†˙ØψÍȉ†Ì‡ ÚÂÓφȄΆÏÙËÓ‰†‡Ù¯φÁ„φÍÈÏÚ†¨˙¯Á‡†‰Ù¯˙·†ÏÂÙȈ‰˙Ú†‰Ê†˙¯Ó‚†Ì‡†Â‡ ˙ˆ·˜‰Ó†˙ÂÙ¯˙†È·‚φ„ÁÂÈÓ·†¨˙ÂÈ˙Ù¯˙≠ÔÈ·†˙·‚˙Ó†ÌÈڷ‰†˙ÂÏÈÚÈ≠ȇ†Â‡†ÌÈÂÎÈÒ ÌÈȄȇ¯ËÒ†‡Ï‰†˙˜Ï„‰†È„‚†˙ÁÙ˘ÓÓ†˙¯Á‡†‰Ù¯˙†ÏΆ‡†ÔȯÈÙÒ‡†∫˙‡·‰ ¨®ÔȯٯÂ†Ô‚Ω†Ì„†˙˘È¯˜†„‚†˙ÂÙ¯˙†¨Ì„†ıÁφ˙„¯Â‰Ï†˙ÂÙ¯˙†¨®ÔÂÊË·ÏÈÙ†„ÁÂÈÓ·© ˙Â˙˘Ó†˙ÂÙ¯˙†¨Ô„‚È˘Ï†„Ȉ·Â¯Ù†¨ÒÈÏËÈ‚È„†Ï˘†ÌÈ„ÈʘÈÏ‚†¨˙ÂÏ˙˘‰Ï†ÔȯÂÙÒÂϘȈ ¨˙ÁÙÒφ‡†Ô˯ÒφˇҘ¯ËÂËÓ†¨‰ÈÒÙÏÈهφ˙ȇ¯Ùφ‰ˆÓÂÁ†¨®„ÈÓÒ¯ÂÙ†∫‡Ó‚„ϩ ÆÌȄȇ¯ËÒ˜È˯˜†¨˙ÂÈȯÂÙÒÂÏÙˆ†˙˜ÈËÂÈ·Èˇ†¨®‰ÈÒ¯ÙÈ„†‰ÈÓ·†ÏÂÙÈËÏ©†ÌÂÈ˙ÈÏ ∫ȇÂÂφ˙ÂÚÙÂ˙ ¨È‡ÂÂφ˙ÂÚÙ˘‰†ÚÈÙ‰φ˙ÂÏÂÏÚ†‰·†˘ÂÓÈ˘‰†ÔÓÊ·†¨‰Ù¯˙‰†Ï˘†‰Èˆ¯‰†˙ÂÏÈÚÙφÛÒ· ÌÈÚˆÙ†¨˙‡˜‰†¨˙¯Ȉچ¨ÏÂ˘Ï˘†¨‰ÏÈÁ·†¨˙ÂÁÈÙ†¨ÔË·†È·‡Î†¨˘‡¯†·‡Î†¨˙¯ÂÁ¯ÁÒ†∫Ô‚ΠƯ‡φ¯˙Ȇ˙Â˘È‚¯Â†ÌÈÈÙ‚·†¯Â¯˜„†‰˘ÂÁ˙†¯ÒÂÁ†¨‰Ù· ∫˙„ÁÂÈÓ†˙ÂÒÁÈÈ˙‰†˙·ÈÈÁÓ‰†È‡ÂÂφ˙ÂÚÙÂ˙ ˙ÈÓ„†‰‡Âˆ†¨ÏÂÎÈÚ†˙ÂÈÚ·†¨Ô‡ÎÈ„†¨„¯Ȃ†¨¯ÂÚ·†‰Áȯن¨Ìȯȯ˘†È·‡Î†¨˙¯Âӯӈ†ÌÂÁ Ô˙Ó·†˙ÂÙÈÁ„†ÌÈ·‡Î†¨˙·¯ˆ†¨ÌÈÙȯÁ†ÔË·†È·‡Î†˙ÂȈÂÂÎ˙‰†¨¯ÂÁ˘†‡È˜†¨‰¯ÂÁ˘†Â‡ ƇÙ¯φÈ؉Ù†ÏÂÙÈˉ†˙‡†ÈؘÒÙ‰†∫®¯È„©†ÌÈÈʇ·†ÌÈψψ†¨‰Èȇ¯·†ÌÈÈÂÈ˘†¨Ô˙˘ ıÁφ¨ÌÈÏÈ‚¯≠È˙Ï·†ÌÈÓÂÓÈ„†Â‡†˙¯·Á†¨®˙ÂȈËÈÙÏÙ©†·Ï†˙˜ÈÙ„†¨Ô˙˘‰†Ú·ˆ·†ÈÂÈ˘ ƇÙ¯φÈ؉Ù†ÏÂÙÈˉ†ÈؘÒÙ‰†∫®¯È„©†ÌÈÈÏ‚¯·†˙ÂÁÈن‡Ø†‰Â·‚†Ì„ ÈؘÒÙ‰†∫‰ÓÈ˘†ÈÈ˘˜†Â‡Ø†Ô¯‚‰†¨ÔÂ˘Ï‰†¨ÌÈÈ˙Ù˘‰†˙ÂÁÙ˙‰†Ô‚Ά˙È‚¯Ï‡†‰·Â‚˙ Æ„ÈÓ†‡Ù¯φÈ؉Ù†ÏÂÙÈˉ ÈÂÈ˘†ÏÁ†Ì‡†Â‡†¨‰Ê†ÔÂÏÚ·†ÂÈȈ†‡Ï˘†È‡ÂÂφ˙ÂÚÙÂ˙†‰Ø˘È‚¯Ó†Íȉ†Â·˘†‰¯˜Ó†Ïη Æ„ÈÓ†‡Ù¯‰†ÌÚ†ıÚÈÈ˙‰Ï†ÍÈÏÚ†˙ÈÏÏΉ†Í˙˘‚¯‰· ∫ÔÂÈÓ Æ„·Ï·†‡Ù¯‰†˙‡¯Â‰†ÈÙφÔÂÈÓ ÆÌÂÈφ‚¢Ó†±≤∞∞†Ï˘†ÏÏÂΆÔÂÈÓ†ÏÚ†¯Â·ÚφÔȇ Æ˙˜ÂÈ˙†ÌÈ„ÏÈφÏÏÎ≠ͯ„·†˙ˆÏÓÂÓ†‰È‡†Âʆ‰Ù¯˙ ÆÏÙËÓ‰†‡Ù¯‰†È„È≠ÏÚ†Ú·˜˘†ÈÙΆÌȷˆ˜†ÌÈÓÊ·†Âʆ‰Ù¯˙·†˘Ó˙˘‰Ï†˘È ÔÙ‡†Ì¢·†Í‡†ª˙¯ÎÊ˘Î†„ÈÓ†‰Ó†ÏÂËÈφ˘È†¨·Âˆ˜†ÔÓÊ·†Âʆ‰Ù¯˙†ÏÂËÈφ˙Á΢†Ì‡ °„ÁÈ·†˙ÂÓ†È˙˘†ÏÂËÈφÔȇ ∫˘ÂÓÈ˘‰†ÔÙ‡ °˘Â˙Îφ‡†˙ˆÁφ¨ÒÂÚÏφÔȇ ƉÙ¯˙‰†˙ÏȈȯÁ‡†‰Ú˘†ÈˆÁ†„Ú†·Î˘Ï†Ôȇ†≠†ÌÈÓ†ÒÂΆÌÚ†‰Ù¯˙‰†˙‡†ÚÂϷφ˘È ƉÁ¯‡‰†È¯Á‡†Â‡†ÌÚ†‰Ù¯˙‰†ÏÂËÈφÔ˙È øÏÂÙÈˉ†˙Áψ‰Ï†ÚÈÈÒφÈØÏÎÂ˙†„ˆÈΠƇÙ¯‰†È„È≠ÏÚ†ıÏÓ‰˘†ÏÂÙÈˉ†˙‡†ÌÈÏ˘‰Ï†ÍÈÏÚ ˙ˆÚÈÈ˙‰†‡Ïφ‰Ù¯˙·†ÏÂÙÈˉ†˙‡†˜ÈÒىφÔȇ†Í˙‡ȯ·†·ˆÓ·†¯ÂÙÈ˘†ÏÁ†Ì‡†Ì‚ ƇÙ¯†ÌÚ °‰ÏÚ¯‰†ÈØÚÓ Â‡Ø†ÌÈ„ÏÈ†Ï˘†Ì„Ȇ‚˘È‰Ï†ıÂÁÓ†¯Â‚̘҆ӷ†¯ÂÓ˘Ï†˘È†˙¯Á‡†‰Ù¯˙†ÏΆÂʆ‰Ù¯˙ ƉÏÚ¯‰†ÈØÚÓ˙†ÍΆȄÈ≠ÏÚ†˙˜ÂÈ˙ Ï˘†ÔÂÈÓ†¯„Áφ„ÈÓ†È؉ن¨‰Ù¯˙‰†ÔÓ†„ÏȆÚÏ·†˙ÂÚË·†Ì‡†Â‡†¯˙Ȇ˙Ó†˙ψ̇ ÆÍ˙ȇ†‰Ù¯˙‰†˙Êȯ‡†È؇·‰Â†¨ÌÈÏÂÁ≠˙È· °‡Ù¯ӆ˙˘¯ÂÙÓ†‰‡¯Â‰†‡Ïφ‰‡˜‰Ï†Ì¯‚φÔȇ ÈØÔ˙˙†Ï‡†Æ˜Èʉφ‰ÏÂÏÚ†‡È‰†˙دÁ‡†‰ÏÂÁ·†¨Í˙ÏÁÓ·†ÏÂÙÈËφ‰Ó˘¯†Âʆ‰Ù¯˙ ÆÍȯÎӆ‡†ÍÈ΢†¨Íȷ¯˜Ï†Âʆ‰Ù¯˙ ƉÙ¯˙†˙ØψÍȉ˘†ÌÚÙ†Ïη†‰Ó‰Â†˙ÈÂÂ˙‰†˜Â„·Ï†˘È†°Í˘ÂÁ·†˙ÂÙ¯˙†ÏÂËÈφÔȇ Æ̉φ‰Ø˜Â˜Ê†Íȉ†Ì‡†ÌÈÈÙ˜˘Ó†·Èί‰Ï†˘È Æ®≤μ∞C©†˘·È†¯È¯˜†Ì˜ӷ†∫‰ÒÁ‡ Æ„·Ï·†˙Ï·‚ÂÓ†‰Ù˜˙φ˙Â¯Ó˘†˙ÂÙ¯˙†¨ÌȈÏÓÂÓ‰†‰ÒÁ‡‰Ø‰Êȯ‡‰†È‡˙†ÈÙφ̂ Á˜Â¯·†ıÚÂÂȉφÍÈÏÚ†¨˜ÙÒ†Ï˘†‰¯˜Ó†Ïη†°¯È˘Î˙‰†Ï˘†‰‚ÂÙ˙‰†Íȯ‡˙φ·Ï†ÌÈ˘Ï†‡ ƉÙ¯˙‰†˙‡†Íφ˜ÙÈÒ˘ ƉÊȯ‡†‰˙‡·†˙¢†˙ÂÙ¯˙†ÔÒÁ‡Ï†Ôȇ ±≥∞∞≥Æ≥∞∑≤∏†∫‚¢Ó†¥∞∞†XL†ÔÙÂ˙‡ ∫‰Ù¯˙‰†ÌÂ˘È¯†ßÒÓ ±≤≤μπÆ≥∞≤∑¥†∫‚¢Ó†∂∞∞†XL†ÔÙÂ˙‡ Æ≤∂±±∞†‰ÙÈÁ†ı¯ÙÓ†¨±∞≥¥∑†Æ„Æ˙†¨Ó¢Ú·†˙ÈÁ˜Â¯†‰È˘Ú˙†Â¯˙††∫Ô¯ˆÈ π∞∞∞¥Æ∞∂±∞ 252 ±π∏∂†≠†Â¢Ó˘˙‰†®ÌÈ¯È˘Î˙© ÌÈÁ˜Â¯‰†˙˜˙†ÈÙφÔίˆÏ†ÔÂÏÚ ‡Ù¯†Ì˘¯Ó·†˙·ÈÈÁ†Âʆ‰Ù¯˙ ‰Ù¯˙·†ÈØ˘Ó˙˘˙†Ì¯Ë·†ÂÙÂÒ†„Ú†ÔÂÏÚ‰†˙‡†ÔÂÈÚ·†È؇¯˜ „È≠ÏÚ†¯˘Â‡Â†˜„·†ÂÎÂ˙†˙‡ȯ·‰†„¯˘Ó†È¢Ú†Ú·˜†‰Ê†ÔÂÏÚ†ËÓ¯ÂÙ XL†ÔÙÂ˙‡ ‚¢Ó†∂∞∞ XL†ÔÙÂ˙‡ ‚¢Ó†¥∞∞ ‰‰˘ÂÓ†¯Â¯Á˘†˙ÂÈÏ·Ë ‰‰˘ÂÓ†¯Â¯Á˘†˙ÂÈÏ·Ë ∫‰ÏÈÎÓ†‰‰˘ÂÓ†¯Â¯Á˘†˙ÈÈϷˆÏÎ Etodolac 600 mg ∫·Î¯‰ ∫‰ÏÈÎÓ†‰‰˘ÂÓ†¯Â¯Á˘†˙ÈÈϷˆÏÎ Etodolac 400 mg ∫ÌÈÏÈÚÙ†È˙Ï·†ÌȯÓÂÁ Microcrystalline cellulose, Hydroxypropyl methylcellulose, Lactose anhydrous, Povidone, Opadry colour (pink or green or grey), Magnesium stearate ÆÊ¢φ‚¢Ó†≥∑Æ≥≥†∫‰ÏÈÎÓ†‚¢Ó†¥∞∞†XL†ÔÙÂ˙‡†‰ÈϷˆÏÎ ÆÊ¢φ‚¢Ó†μ∂Æ∞∞†∫‰ÏÈÎÓ†‚¢Ó†∂∞∞†XL†ÔÙÂ˙‡†‰ÈϷˆÏÎ Æ(NSAIDs)†ÌȄȇ¯ËÒ†Ìȇ˘†˙˜Ï„†È„‚†∫˙ÈËÈÂÙ¯˙†‰ˆÂ·˜ ∫˙ȇÂÙ¯†˙ÂÏÈÚÙ ÒÈËȯ˯‡Â‡ÈËÒ‡† ÈÈÓÒ˙·† ÏÂÙÈËφ ˘Ó˘Ó† ¨È˙˜Ï„† Èˇ† Ȅȇ¯ËÒ† ‡Ï† ¯È˘Î˙ ÆÒÈËȯ˯‡†„ȇÂËÓ‡¯Â ø¯È˘Î˙·†˘Ó˙˘‰Ï†Ôȇ†È˙Ó ˙¯Á‡†˙ÂÙ¯˙φ‡†‰È·ÈίÓÓ†„Á‡Ï†˙Â˘È‚¯†Íφ‰Ú„Ȇ̇†‰Ù¯˙·†˘Ó˙˘‰Ï†Ôȇ ÆÔȯÈÙÒ‡†ÏÏÂΆ¨‰ˆÂ·˜†‰˙‡ӆÌÈ·‡Î†ÍÂÎÈ˘Ï ÆÔÂȯ‰‰†ÛÂÒ·†‰Ù¯˙·†È˘Ó˙˘˙†Ï‡ ¨‰ÁȯنÔ‚Ά¨˙ÂÙȯÁ†˙ÂÈ‚¯Ï‡†˙ÂÚÙÂ˙Ó†˙ØÏ·ÂÒ†Íȉ†Ì‡†‰Ù¯˙·†˘Ó˙˘‰Ï†Ôȇ ˙ÈÏȈÈÏÒ†ÏÈˈ‡†‰ˆÓÂÁ·†˘ÂÓÈ˘Ó†‰‡ˆÂ˙Άۇ·†ÌÈÙÈÏÂÙ†ÌÚ†·ÂÏÈ˘·†‰Ó˙҇ӆ‡ Æ˙ÂȄȇ¯ËÒ†‡Ï‰†˙˜Ï„‰†˙„‚†˙ÂÙ¯˙‰†˙ÁÙ˘ÓÓ†˙¯Á‡†‰Ù¯˙†Ïη†Â‡ ÆÏÈÚÙ†ÈÏÂÎÈÚ†·ÈÎÓ†¯·Ú·†˙Ϸ҆‡†˙ØÏ·ÂÒ†Íȉ†Ì‡†‰Ù¯˙·†˘Ó˙˘‰Ï†Ôȇ ÆÌÈÙ˜ÚÓ†ÁÂ˙ȆȯÁ‡†Â‡†ÈÙφÂʆ‰Ù¯˙·†˘Ó˙˘‰Ï†Ôȇ ∫ÏÂÙÈˉ†˙ÏÁ˙‰†ÈÙφ‡Ù¯·†ıÚÂÂȉφÈÏ·Ó†‰Ù¯˙·†˘Ó˙˘‰Ï†Ôȇ Ɖ˜ÈÈӆ‡†ÔÂȯ‰·†Íȉ†Ì‡ ¨Ô˙˘‰†˙ίÚÓ؉ÈÏΉ†¨„·Î‰†∫„˜Ù˙·†È˜ÈÏÓ†¯·Ú·†˙Ϸ҆‡†˙ØÏ·ÂÒ†Íȉ†Ì‡ Ô‚Ω†‰ÓÈ˘‰†˙ίÚÓ†¨®‰˘È¯˜†Ô‚Ω†Ì„‰†˙ίÚÓ†¨®Ò˜Ï‡†Ô‚Ω†ÏÂÎÈÚ‰†˙ίÚÓ ÆÌÈÏʆ˙¯È·ˆ†Ï˘†˙ÂÈÚ·Ó†‰Â·‚†Ì„†ıÁÏÓ†¨˙¯ÎÂÒÓ†¨·Ï‰†¨®‰Ó˙Ò‡ øÍÏ˘†ÌÂȆÌÂȉ†ÈÈÁ†ÏÚ†‰Ù¯˙‰†ÚÈÙ˘˙†Íȇ ¯È·‚‰Ï†‰ÏÂÏÚ†‰Ù¯˙‰†ÌÚ†ÏÂÙÈˉ†˙Ù˜˙·†Ô¢Èچ‡†ÌÈÙȯÁ†˙‡˜˘Ó†¨˙ÂÈȆ˙ÈÈ˙˘ ÆÏÂÎÈÚ‰†˙ίÚÓ·†·ÈΆ˙¯ˆÂÂȉφÔÂÎÈÒ‰†˙‡ ∫˙¯‰Ê‡ ÆÂφÌÈ˘È‚¯‰†ÌÈ˘‡†Ïˆ‡†‰È‚¯Ï‡Ï†Ì¯‚φÏÂÏÚ‰†Ê¢φÏÈÎÓ†¯È˘Î˙‰ ¨ı·˘Ï†Â‡†·Ï†Û˜˙‰Ï†ÔÂÎÈÒ‰†˙‡†˙ÂÏډφ˙ÂÏÂÏÚ†≠†NSAIDs†≠‰†˙ÁÙ˘ÓÓ†˙ÂÙ¯˙ ¯˙ÂÈ·†ÍÂÓ‰†ÏÈÚȉ†ÔÂÈÓ·†˘Ó˙˘‰Ï†˘È†Æ͢ÂÓÓ†ÏÂÙȈ¯Á‡Ï†Â‡†·Ï†ÈÏÂÁ·†„ÁÂÈÓ· Æȯ˘Ù‡‰†¯˙ÂÈ·†¯ˆ˜‰†ÔÓʉ†Í˘ÓÏ ˘ÂÓÈ˘‰†ÏÚ†‡Ù¯φÚȄ‰φ˘È†¨ÌÈÈÈ˘·†È‚¯Â¯ÈΆÏÂÙȈÏÏÂΆ¨˙È‚¯Â¯ÈΆ‰ÏÂÚÙ†ÏΆÈÙÏ Æ¯È˘Î˙· ÏÂÏÚ†ÏÂÙÈˉ†¯Á‡Ó†˙ÂÈ˙„·ÚÓ†˙˜Ȅ·†¯Â·Úφ˙Ø„ÓÂÚ†Íȉ†Ì‡†‡Ù¯φÁ„φÍÈÏÚ Æ‰˜È„·‰†˙‡ˆÂ˙φÚÈ¯Ù‰Ï ÌȄȇ¯ËÒ†Ìȇ˘†˙˜Ï„†È„‚†˙ˆÂ·˜Ï†ÌÈÎÈÈ˘‰†ÌȯÁ‡†ÌÈ¯È˘Î˙†ÂÓΆ‰Ê†¯È˘Î˙ ÌÈ˘‡·†∫Ìȇ·‰†Ìȯ˜Ó·†„ÁÂÈÓ·†‰·È˜·†ÌÂÓȄφÔÂÎÈÒ‰†˙‡†¯È·‚‰Ï†ÏÂÏÚ†®NSAID© ˘ÂÓÈ˘·†¨˙¯Á‡†NSAID†˙ÂÙ¯˙†ÌȄȇ¯ËÒ†¨Ì„†ÏÂÏȄφ˙ÂÙ¯˙†˙ÈÓÊ≠·†ÌÈÏˉ ÆωÂÎχ†˙Îȯˆ·Â†¯È˘Î˙·†Í˘ÂÓÓ ÈÙφ‡Ù¯φÍÎ≠ÏÚ†ÚȄ‰φÍÈÏÚ†¨È‰˘ÏΆ‰Ù¯˙φ‡†Â‰˘ÏΆÔÂÊÓφ‰Ø˘È‚¯†Íȉ†Ì‡ ƉÙ¯˙‰†˙ÏÈË ˙ίÚÓφ‰ÈÏÎφ¨„·Îφ˙Â¯Â˘˜‰†È‡ÂÂφ˙ÂÚÙÂ˙†Á˙ÙφÌÈÏÂÏÚ‰†≠†ÌÈ˘È˘˜·†˙Â¯È‰Ê ÆÏÂÎÈÚ‰ 252 PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE PHARMACISTS' REGULATIONS (PREPARATIONS) - 1986 The dispensing of this medicine requires a doctor's prescription Read this package insert carefully in its entirety before using this medicine The format of this leaflet was determined by the Ministry of Health and its content was checked and approved ETOPAN XL 400 mg ETOPAN XL 600 mg Extended-release tablets Extended-release tablets Composition: Each extended-release tablet contains: Each extended-release tablet contains: Etodolac 400 mg Etodolac 600 mg Inactive ingredients: Microcrystalline cellulose, Hydroxypropyl methylcellulose, Lactose anhydrous, Povidone, Opadry colour (pink or green or grey), Magnesium stearate Each ETOPAN XL 400 mg tablet contains: 37.33 mg lactose. Each ETOPAN XL 600 mg tablet contains: 56.00 mg lactose. Therapeutic group: Nonsteroidal anti-inflammatory drugs (NSAIDs). Therapeutic activity: A nonsteroidal anti-inflammatory drug for the management of osteoarthritis and rheumatoid arthritis symptoms. When should the preparation not be used? Do not use this medicine if you are sensitive to any of its ingredients or to other drugs for the management of pain from the same group, including aspirin. Do not use this medicine in late pregnancy. Do not use this medicine if you suffer from severe allergic reactions, e.g. rash, or from asthma in conjunction with nasal polyps due to using acetylsalicylic acid or any other nonsteroidal anti-inflammatory drug. Do not use this medicine if you suffer, or have suffered in the past, from active peptic ulcer. Do not use this medicine before or after bypass surgery. Do not take this medicine without consulting a doctor before starting treatment: If you are pregnant or breastfeeding. If you are suffering, or have suffered in the past, from impaired function of: the liver, the kidney/urinary tract, the digestive system (e.g. ulcer), the blood system (e.g. coagulation disorder), the respiratory system (e.g. asthma), the heart, from diabetes mellitus, hypertension and from fluid retention problems. How will this medicine affect your daily life? Drinking wine, alcoholic beverages or smoking while under treatment with this medicine may increase the risk of gastrointestinal ulceration. Warnings: The preparation contains lactose and may cause an allergic reaction in patients sensitive to lactose. NSAID medications may increase the risk of heart attack or stroke, especially in patients with heart disease or after prolonged treatment. Use the lowest effective dose for the shortest possible duration of treatment. Before any surgical treatment, including dental surgery, inform your doctor that you are using this medicine. Inform your doctor if you are going to undergo laboratory tests because the use of this drug may interfere with test results. As with other preparations belonging to the group of nonsteroidal anti-inflammatory drugs (NSAIDs), this preparation may increase the risk of gastric bleeding, especially in the following cases: in people concomitantly taking blood thinners, steroids and other NSAIDs, in prolonged use of the preparation and when consuming alcohol. If you are sensitive to any type of food or medicine, inform your doctor before commencing treatment with this medicine. Caution is recommended in geriatric patients, who may develop adverse hepatic, renal and gastrointestinal effects. Drug interactions: If you are taking another drug concomitantly, including non-prescription medicines and nutritional supplements, or if you have just finished treatment with another medicine, inform the attending doctor, in order to prevent hazards or lack of efficacy arising from drug interactions. This is especially important for medicines belonging to the following groups: aspirin or any other nonsteroidal anti-inflammatory drugs (especially phenylbutazone), antihypertensives, anticoagulants (e.g. warfarin), cyclosporin for organ transplants, digitalis glycosides, probenecid for gout, diuretics (for example: furosemide), valproic acid for epilepsy, methotrexate for cancer or psoriasis, lithium (for treatment of bipolar disorder), cephalosporin antibiotics, corticosteroids. Side effects: In addition to the desired effect of the medicine, adverse reactions may occur during the course of taking this medicine, for example: dizziness, headache, stomach ache, bloating, nausea, diarrhea, constipation, vomiting, mouth sores, numbness and pricking sensation in the limbs and hypersensitivity to light. Effects that require special attention: Fever and chills, muscle aches, skin rash, itching, depression, digestive problems, blood in the stools or black stools, black vomit, acute abdominal spasms and pain, heartburn, painful and urgent urinating, changes in vision, tinnitus (rare): stop treatment and consult your doctor. Change in the color of urine, palpitations, unusual bleeding or bruising, high blood pressure and/or swelling of the legs (rare): stop treatment and refer to the doctor. Allergic reaction such as swelling of the lips, tongue, throat and/or breathing difficulties: stop treatment and refer to the doctor immediately. In the event that you experience side effects not mentioned in this leaflet, or if there is a change in your general health, consult your doctor immediately. Dosage: Dosage is according to doctor's instructions only. Do not exceed a total daily dosage of 1200 mg. This medicine is not usually recommended for administration to children and infants. This medicine is to be taken at specific time intervals as determined by the attending doctor. If you forget to take this medicine at the specified time, take the dose as soon as you remember, but never take a double dose to compensate for a missed one! Directions for use: Do not chew, halve or crush! Swallow the medicine with a glass of water - do not lie down for 30 minutes after taking the medicine. Take the medicine with or after a meal. How can you contribute to the success of the treatment? Complete the full course of treatment as instructed by the doctor. Even if there is an improvement in your health, do not discontinue use of this medicine without consulting your doctor. Avoid poisoning! This medicine, and all other medicines, must be stored in a safe place out of the reach of children and/or infants, to avoid poisoning. If you have taken an overdose, or if a child has accidentally swallowed the medicine, proceed immediately to a hospital emergency room and bring the package of the medicine with you. Do not induce vomiting unless explicitly instructed to do so by a doctor! This medicine has been prescribed for the treatment of your ailment; in another patient it may cause harm. Do not give this medicine to your relatives, neighbours or friends. Do not take medicines in the dark! Check the label and the dose each time you take your medicine. Wear glasses if you need them. Storage: Store in a cool and dry place (250C). Even if kept in their original container and stored as recommended, medicines may be kept for a limited period only. Please note the expiry date of the medicine! In case of doubt, consult the pharmacist who dispensed the medicine to you. Do not store different medications in the same package. License number: ETOPAN XL 400 mg: 13003.30728 ETOPAN XL 600 mg: 12259.30274 Manufacturer: Taro Pharmaceutical Industries Ltd., P.O.Box 10347, Haifa Bay 26110.